English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Digital twin hearts improve outcomes in arrhythmia ablation procedures
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study shows pralsetinib improves survival in RET fusion-positive lung cancer patients
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study finds walking is most common activity but few meet exercise guidelines
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study finds AI scribes modestly reduce clinician documentation time and EHR use
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Mount Sinai enrolls first patient in trial for postpartum depression brain stimulation therapy
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Semaglutide linked to sharp drop in alcohol use in single case report
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study finds gender and lifestyle differences in salt-adding habits among older adults
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

BioNTech to close Singapore mRNA manufacturing site amid shift in strategy

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones